IQVIA

iqvia.com · Durham, United States of America

IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, helping pharmaceutical, biotech, and healthcare organizations design, run, and optimize clinical trials and commercial operations. The company combines healthcare data, software platforms, and contract research services to support drug development, real-world evidence generation, and market access. It generates revenue through long-term service contracts, technology subscriptions, and data and consulting engagements with life sciences and healthcare clients worldwide.

  • IT Consulting & Implementation
  • Business Intelligence & Dashboards
  • Clinical Trial & Research Software
Revenue
$15.0B
Employees
86,000
Founded
2016
Headquarters
Durham, United States of America

What 245 Arbolus experts think of IQVIA

NPS scores for IQVIA are predominantly positive, with strong scores (8–10) among both high- and mid-spending customers and users in regulatory and commercial positions. Renewal intent is generally strong in the high-spending segment, less certain among mid-tier and influencers, with some citing future budget reductions due to project expirations. Stickiness is reflected by the prevalence of long-tenure implementations and routine global usage. Key feedback themes highlight robust platform maturity, price competitiveness, and credibility of data, with cited weaknesses around slow data-to-action cycles and lack of innovation in supplementary products.Overall Customer Sentiment: Positive

Who reviewed IQVIA

Total customers 245 228 current · 17 former
Reviews growth +51 in six months
Seniority of respondents
  • C-Suite 60% (147)
  • Director 32% (78)
  • Manager 8% (20)
Operations Leader Director NPS 8 Undecided
Marketing Leader C-Suite NPS 10
Marketing Leader C-Suite NPS 8

Employer names and spend open in the full report, along with the other 242 customers.

Everything 245 customers told us about IQVIA.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Open the full report

Sentiment

27 Net Promoter Score, from 245 scored reviews
  • Promoters 102
  • Passives 108
  • Detractors 35

Cumulative NPS by month

+0 over 6 months
  • Apr 8
  • May 8
  • Jun 8
  • Jul 8
  • Aug 8
  • Sep 8

Net Promoter Score across 8 reviews, accumulated up to each month. Category median 28 across 8 companies.

Praised

  • Expanding Supplemental Product Portfolio
  • AI-Enabled Data Insights
  • Advanced Workflow Integration
  • Credible Data for Market Insights

Criticised

  • Switching on Data Usability
  • Competitive AI Displacement
  • Lag in Product Innovation
  • Data Actionability Gap

What customers say

Credible Data for Market Insights
“IQVIA’s depth and credibility of market data make it valuable for understanding market share, competition, and supporting forecasting.”
Robust Platform and Implementation
“IQVIA is a well-chosen, affordable, and effective regulatory information management tool, and we very much appreciate its effectiveness globally.”
Effective Regulatory Workflow Support
“Submission tracking and managing health authorities are handled very effectively in IQVIA, and the platform is used daily by our team.”

Renewal intent

Plan to renew 36%
  • Will renew 72
  • Undecided 122
  • Not renewing 5

Plan to renew, by seniority

  • C-Suite 32% 116 answers
  • Director 44% 64 answers
  • Manager 35% 17 answers
  • Not specified 50% 2 answers
  • 8.3/10 Average score from customers who will renew
  • 7.7/10 Average score from undecided customers
  • 5.4/10 Average score from customers not renewing

Top alternatives

Most weighed by IQVIA customers

Report

For people who use IQVIA

Do you use IQVIA at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 245 customers of IQVIA have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.